Antibiotic Prophylaxis in Rhinoplasty

Trial ID or NCT#

NCT04194216

Status

recruiting iconRECRUITING

Purpose

This study compares the efficacy of a single intra-operative (intravenous) dose of "cephalexin" (first generation cephalosporin) or "clindamycin" (lincosamides), alone versus both intra-operative (intravenous) dose of "cephalexin" (first generation cephalosporin) or "clindamycin" (lincosamides) and postoperative oral dose of "cephalexin" or "clindamycin" use in nasal surgery.

Official Title

Comparison of Outcomes in Rhinoplasty With the Use of Intraoperative Versus Postoperative Antibiotics

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. Adult patients (aged 18years and older)
Exclusion Criteria:
  1. - Prior rhinoplasty - Any exogenous (non-nasal) grafts/implants - Immune deficiency (DM, meds, other) - History of radiotherapy to nose
View All Criteria
Show Less

Investigator(s)

Sam P. Most, MD, FACS
Sam P. Most, MD, FACS
Facial plastic surgeon, Ear, nose, and throat specialist
Professor of Otolaryngology - Head & Neck Surgery (OHNS)

Contact us to find out if this trial is right for you.

Contact

Sam P Most, MD
6507363223

SEND MESSAGE

View on ClinicalTrials.gov